Inhibition profiles of Voriconazole against acetylcholinesterase, α-glycosidase, and human carbonic anhydrase I and II isoenzymes

MakaleYalnız künye
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

In this work, the inhibitory activity of Voriconazole was measured against some metabolic enzymes, including human carbonic anhydrase (hCA) I and II isoenzymes, acetylcholinesterase (AChE), and α-glycosidase; the results were compared with standard compounds including acetazolamide, tacrine, and acarbose. Half maximal inhibition concentration (IC50) values were obtained from the enzyme activity (%)-[Voriconazole] graphs, whereas Ki values were calculated from the Lineweaver-Burk graphs. According to the results, the IC50 value of Voriconazole was 40.77 nM for α-glycosidase, while the mean inhibition constant (Ki) value was 17.47 ± 1.51 nM for α-glycosidase. The results make an important contribution to drug design and have pharmacological applications. In addition, the Voriconazole compound demonstrated excellent inhibitory effects against AChE and hCA isoforms I and II. Voriconazole had Ki values of 29.13 ± 3.57 nM against hCA I, 15.92 ± 1.90 nM against hCA II, and 10.50 ± 2.46 nM against AChE.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/12661Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/jbt.22385Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTopal, Fevzi
dc.date.accessioned2026-10-22T10:20:23.131723422Z
dc.date.available2026-10-22T10:20:23.131723422Z
dc.date.issued2019
dc.description.abstractIn this work, the inhibitory activity of Voriconazole was measured against some metabolic enzymes, including human carbonic anhydrase (hCA) I and II isoenzymes, acetylcholinesterase (AChE), and α-glycosidase; the results were compared with standard compounds including acetazolamide, tacrine, and acarbose. Half maximal inhibition concentration (IC50) values were obtained from the enzyme activity (%)-[Voriconazole] graphs, whereas Ki values were calculated from the Lineweaver-Burk graphs. According to the results, the IC50 value of Voriconazole was 40.77 nM for α-glycosidase, while the mean inhibition constant (Ki) value was 17.47 ± 1.51 nM for α-glycosidase. The results make an important contribution to drug design and have pharmacological applications. In addition, the Voriconazole compound demonstrated excellent inhibitory effects against AChE and hCA isoforms I and II. Voriconazole had Ki values of 29.13 ± 3.57 nM against hCA I, 15.92 ± 1.90 nM against hCA II, and 10.50 ± 2.46 nM against AChE.
dc.identifier.articlenumbere22385
dc.identifier.doi10.1002/jbt.22385
dc.identifier.eissn1099-0461
dc.identifier.issn1095-6670
dc.identifier.issue10
dc.identifier.pmid31478295
dc.identifier.scopus2-s2.0-85071606975
dc.identifier.startpagee22385
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/12661
dc.identifier.volume33
dc.identifier.wosWOS:000484846800001
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc.
dc.relation.ispartofJournal of Biochemical and Molecular Toxicology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectacetylcholinesterase
dc.subjectcarbonic anhydrase
dc.subjectenzyme inhibition
dc.subjectvoriconazole
dc.subjectα-glycosidase
dc.subject.classificationBiochemistry & Molecular Biology
dc.subject.classificationToxicology
dc.subject.otherAcetylcholinesterase
dc.subject.otherAntifungal Agents
dc.subject.otherCarbonic Anhydrase I
dc.subject.otherCarbonic Anhydrase II
dc.subject.otherCarbonic Anhydrase Inhibitors
dc.subject.otherGlycoside Hydrolases
dc.subject.otherHumans
dc.subject.otherVoriconazole
dc.subject.otheracarbose
dc.subject.otheracetazolamide
dc.subject.otheralpha glycosidase
dc.subject.othercarbonate dehydratase I
dc.subject.othercarbonate dehydratase II
dc.subject.otherglycosidase
dc.subject.othertacrine
dc.subject.otherunclassified drug
dc.subject.otherantifungal agent
dc.subject.othercarbonate dehydratase inhibitor
dc.subject.otherArticle
dc.subject.othercompetitive inhibition
dc.subject.othercontrolled study
dc.subject.otherdrug design
dc.subject.otherenzyme activity
dc.subject.otherenzyme inhibition
dc.subject.otherenzyme inhibition assay
dc.subject.otherhuman
dc.subject.otherIC50
dc.subject.otherinhibition constant
dc.subject.otherdrug effect
dc.titleInhibition profiles of Voriconazole against acetylcholinesterase, α-glycosidase, and human carbonic anhydrase I and II isoenzymes
dc.typeArticle
dspace.entity.typePublication
rdl.citation.openalex30
rdl.citation.scopus32
rdl.citation.wos30
rdl.departmentDepartment of Chemical and Chemical Processing Technologies, Laboratory Technology Program, Gumushane Vocational School, Gumushane University, Gumushane, Turkey
rdl.oa.statusclosed
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)